| scholarly article | Q13442814 |
| P2093 | author name string | Bakhos A Tannous | |
| Jian Teng | |||
| Christian E Badr | |||
| Seyedali Hejazi | |||
| P2860 | cites work | DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance | Q26825975 |
| Transmigration of neural stem cells across the blood brain barrier induced by glioma cells | Q27329613 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors | Q33779347 | ||
| Functional drug screening assay reveals potential glioma therapeutics | Q33780121 | ||
| Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage? | Q34078735 | ||
| Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform | Q34691557 | ||
| Novel therapeutic applications of cardiac glycosides | Q34864765 | ||
| Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway | Q35419466 | ||
| Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. | Q35665706 | ||
| Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. | Q35696355 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Emerging insights into the molecular and cellular basis of glioblastoma | Q35914897 | ||
| Targeting cancer cells with the natural compound obtusaquinone. | Q36953575 | ||
| Triple bioluminescence imaging for in vivo monitoring of cellular processes. | Q36968192 | ||
| Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo | Q37217394 | ||
| A secreted luciferase for ex vivo monitoring of in vivo processes | Q37235465 | ||
| The TRAIL apoptotic pathway in cancer onset, progression and therapy | Q37278043 | ||
| Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. | Q37344283 | ||
| Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies | Q37396577 | ||
| TRAIL on trial: preclinical advances in cancer therapy | Q37433463 | ||
| Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors | Q37447217 | ||
| Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge | Q37729676 | ||
| Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone | Q37879267 | ||
| Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection | Q38006628 | ||
| Advances in stem cell therapy against gliomas | Q38093919 | ||
| Glioblastoma and other malignant gliomas: a clinical review. | Q38160159 | ||
| Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma | Q39374075 | ||
| Microvesicle-associated AAV vector as a novel gene delivery system | Q39400043 | ||
| A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models | Q39630653 | ||
| Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Glioma Therapy | Q39644411 | ||
| Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo | Q41723484 | ||
| Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression | Q42835214 | ||
| Absorption and metabolism of lanatoside C. II. Fate after oral administration | Q44128474 | ||
| Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo | Q44611172 | ||
| Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. | Q45890216 | ||
| In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models | Q48876895 | ||
| Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies | Q49069202 | ||
| P433 | issue | 8 | |
| P921 | main subject | glioblastoma | Q282142 |
| neural stem cell | Q2944097 | ||
| P304 | page(s) | 2021-2032 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy | |
| P478 | volume | 32 |
| Q33902853 | Elimination of undifferentiated human embryonic stem cells by cardiac glycosides |
| Q91604362 | Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs |
| Q99207673 | Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients |
| Q36919260 | Imaging Tumor Vascularity and Response to Anti-Angiogenic Therapy Using Gaussia Luciferase |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q26783167 | Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme |
| Q38626364 | New therapeutic strategies regarding endovascular treatment of glioblastoma, the role of the blood-brain barrier and new ways to bypass it. |
| Q91765663 | Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy |
| Q47988508 | Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype. |
| Q37109638 | The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells |
| Q36636067 | Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic. |
Search more.